Fine epitope mapping of monoclonal antibodies against hemagglutinin of a highly pathogenic H5N1 influenza virus using yeast surface display

Biochemical and Biophysical Research Communications

Volumn 409, Issue 2, 2011, Pages 253-259

  Han, Thomas ^a   Sui, Jianhua ^a   Bennett, Andrew S ^a   Liddington, Robert C ^b   Donis, Ruben O ^c   Zhu, Quan ^a   Marasco, Wayne A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BURNHAM INSTITUTE   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Fine epitope mapping; H5N1; Influenza; Yeast surface display

Indexed keywords

INFLUENZA VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGENICITY; ARTICLE; BINDING SITE; CLADISTICS; CONFORMATION; CRYSTAL STRUCTURE; EPITOPE MAPPING; ESCAPE BEHAVIOR; INFLUENZA VIRUS A H5N1; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR BINDING; SURFACE PROPERTY; VIRUS ATTACHMENT; VIRUS INHIBITION; YEAST;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CLONING, MOLECULAR; EPITOPE MAPPING; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MUTATION; PEPTIDE LIBRARY; SACCHAROMYCES CEREVISIAE;

AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE;

EID: 79957901666     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.139     Document Type: Article

References (12)

1. Subbarao K., Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat. Rev. Immunol. 2007, 7:267-278.
2. Han T., Marasco W.A. Structural basis of influenza virus neutralization. Ann. N. Y. Acad. Sci. 2011.
3. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., Wan H., Murakami A., Yammanuru A., Han T., Cox N.J., Bankston L.A., Donis R.O., Liddington R.C., Marasco W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 2009, 16:265-273.
4. Pepper L.R., Cho Y.K., Boder E.T., Shusta E.V. A decade of yeast surface display technology: where are we now?. Comb Chem. High Throughput Screen 2008, 11:127-134.
5. Altmann M., Linder P. Power of yeast for analysis of eukaryotic translation initiation. J. Biol. Chem. 2010, 285:31907-31912.
6. Cochran J.R., Kim Y.S., Olsen M.J., Bhandari R., Wittrup K.D. Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments. J. Immunol. Methods 2004, 287:147-158.
7. Levy R., Forsyth C.M., LaPorte S.L., Geren I.N., Smith L.A., Marks J.D. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. J. Mol. Biol. 2007, 365:196-210.
8. Oliphant T., Engle M., Nybakken G.E., Doane C., Johnson S., Huang L., Gorlatov S., Mehlhop E., Marri A., Chung K.M., Ebel G.D., Kramer L.D., Fremont D.H., Diamond M.S. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 2005, 11:522-530.
9. Li J., Wang Y., Liang Y., Ni B., Wan Y., Liao Z., Chan K.H., Yuen K.Y., Fu X., Shang X., Wang S., Yi D., Guo B., Di B., Wang M., Che X., Wu Y. Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display. Eur. J. Immunol. 2009, 39:3498-3510.
10. Wang C.Y., Luo Y.L., Chen Y.T., Li S.K., Lin C.H., Hsieh Y.C., Liu H.J. The cleavage of the hemagglutinin protein of H5N2 avian influenza virus in yeast. J. Virol. Methods 2007, 146:293-297.
11. Wasilenko J.L., Sarmento L., Spatz S., Pantin-Jackwood M. Cell surface display of highly pathogenic avian influenza virus hemagglutinin on the surface of Pichia pastoris cells using alpha-agglutinin for production of oral vaccines. Biotechnol. Prog. 2010, 26:542-547.
12. Benne C.A., Kroon F.P., Harmsen M., Tavares L., Kraaijeveld C.A., De Jong J.C. Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals. Clin. Diagn. Lab. Immunol. 1998, 5:114-117.